Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia.

Korner, Judith

Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia. [electronic resource] - Obesity research Feb 2003 - 311-2 p. digital

Publication Type: Letter

1071-7323

10.1038/oby.2003.46 doi


Anti-Obesity Agents
Cabergoline
Ergolines--adverse effects
Female
Humans
Hyperprolactinemia--drug therapy
Male
Weight Loss